Literature DB >> 19185953

Topical tar: back to the future.

Kapila V Paghdal1, Robert A Schwartz.   

Abstract

The use of medicinal tar for dermatologic disorders dates back to the ancient times. Although coal tar is utilized more frequently in modern dermatology, wood tars have also been widely employed. Tar is used mainly in the treatment of chronic stable plaque psoriasis, scalp psoriasis, atopic dermatitis, and seborrheic dermatitis, either alone or in combination therapy with other medications, phototherapy, or both. Many modifications have been made to tar preparations to increase their acceptability, as some dislike its odor, messy application, and staining of clothing. One should consider a tried and true treatment with tar that has led to clearing of lesions and prolonged remission times. Occupational studies have demonstrated the carcinogenicity of tar; however, epidemiologic studies do not confirm similar outcomes when used topically. This article will review the pharmacology, formulations, efficacy, and adverse effects of crude coal tar and other tars in the treatment of selected dermatologic conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185953     DOI: 10.1016/j.jaad.2008.11.024

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  15 in total

1.  Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas.

Authors:  Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

Review 2.  Management of itch in atopic dermatitis.

Authors:  Judith Hong; Joerg Buddenkotte; Timothy G Berger; Martin Steinhoff
Journal:  Semin Cutan Med Surg       Date:  2011-06

3.  Coal tar 2% foam in combination with a superpotent corticosteroid foam for plaque psoriasis: case report and clinical implications.

Authors:  Amylynne J Frankel; Joshua A Zeichner; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2010-10

Review 4.  Topical treatments for scalp psoriasis.

Authors:  Justin Gabriel Schlager; Stefanie Rosumeck; Ricardo Niklas Werner; Anja Jacobs; Jochen Schmitt; Christoph Schlager; Alexander Nast
Journal:  Cochrane Database Syst Rev       Date:  2016-02-26

5.  Selected Inflammatory and Metabolic Markers in Psoriatic Patients Treated with Goeckerman Therapy.

Authors:  Katerina Kondelkova; Lenka Borska; Ctirad Andrys; Jan Krejsek; Kvetoslava Hamakova; Simona Rendarova; Vit Rehacek; Jan Kremlacek; Zdenek Fiala
Journal:  Mediators Inflamm       Date:  2015-06-08       Impact factor: 4.711

6.  Comparing the efficacy of Emu oil with clotrimazole and hydrocortisone in the treatment of seborrheic dermatitis: A clinical trial.

Authors:  Yalda Attarzadeh; Ali Asilian; Zabihollah Shahmoradi; Neda Adibi
Journal:  J Res Med Sci       Date:  2013-06       Impact factor: 1.852

7.  Benzimidazoisoquinolines: a new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent Tregs and prevent murine graft-versus-host disease.

Authors:  Sumit Punj; Prasad Kopparapu; Hyo Sang Jang; Jessica L Phillips; Jamie Pennington; Diana Rohlman; Edmond O'Donnell; Patrick L Iversen; Siva Kumar Kolluri; Nancy I Kerkvliet
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

8.  Serum level of antibody against benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in people dermally exposed to PAHs.

Authors:  Lenka Borska; Ctirad Andrys; Jan Krejsek; Vladimir Palicka; Marcela Chmelarova; Kvetoslava Hamakova; Jan Kremlacek; Pavel Borsky; Zdenek Fiala
Journal:  J Immunol Res       Date:  2014-04-13       Impact factor: 4.818

9.  Oxidative damage to nucleic acids and benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and chromosomal aberration in children with psoriasis repeatedly exposed to crude coal tar ointment and UV radiation.

Authors:  Lenka Borska; Ctirad Andrys; Jan Krejsek; Vladimir Palicka; Marcela Chmelarova; Kvetoslava Hamakova; Jan Kremlacek; Zdenek Fiala
Journal:  Oxid Med Cell Longev       Date:  2014-08-12       Impact factor: 6.543

10.  An open label prospective randomized trial to compare the efficacy of coal tar-salicylic Acid ointment versus calcipotriol/betamethasone dipropionate ointment in the treatment of limited chronic plaque psoriasis.

Authors:  Sujay Khandpur; Kanika Sahni
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.